TY - JOUR
T1 - Somatisation as a risk factor for incident depression and anxiety
AU - Dijkstra-Kersten, S.M.A.
AU - Sitnikova, K.
AU - van Marwijk, H.W.J.
AU - Gerrits, M.J.G.
AU - van der Wouden, J.C.
AU - Penninx, B.W.J.H.
AU - van der Horst, H.E.
AU - Leone, S.S.
PY - 2015
Y1 - 2015
N2 - Objective: In this study, we aimed to examine somatisation as a risk factor for the onset of depressive and anxiety disorders. Methods: 4-year follow-up data from the Netherlands Study of Depression and Anxiety (NESDA), a multisite cohort study of the course of depression and anxiety, was analysed. Participants (18-65 years) without a lifetime depressive or anxiety disorder at baseline were included (n = 611). Somatisation was measured at baseline with the somatisation subscale of the 4 Dimensional Symptoms Questionnaire. Onset of depression and anxiety was assessed with the CIDI interview at 2-year and 4-year follow-up. Results: Somatisation was a risk factor for the incidence of depression [Hazard Ratio per unit increase (HR); 95% Confidence Interval (CI): 1.13; 1.09-1.17] and anxiety [HR; 95% CI: 1.14; 1.09-1.18]. Associations attenuated but remained statistically significant after adjusting for socio-demographic characteristics, chronic somatic disorders, and baseline levels of (subclinical) depressive or anxiety symptoms [adjusted HR for depression; 95% CI: 1.06; 1.00-1.12, adjusted HR for anxiety; 95% CI: 1.13; 1.07-1.20]. Conclusion: Persons who somatise have an increased risk of becoming depressed or anxious in subsequent years, over and above baseline levels of depressive or anxiety symptoms. They may represent a target group for prevention of depressive and anxiety disorders.
AB - Objective: In this study, we aimed to examine somatisation as a risk factor for the onset of depressive and anxiety disorders. Methods: 4-year follow-up data from the Netherlands Study of Depression and Anxiety (NESDA), a multisite cohort study of the course of depression and anxiety, was analysed. Participants (18-65 years) without a lifetime depressive or anxiety disorder at baseline were included (n = 611). Somatisation was measured at baseline with the somatisation subscale of the 4 Dimensional Symptoms Questionnaire. Onset of depression and anxiety was assessed with the CIDI interview at 2-year and 4-year follow-up. Results: Somatisation was a risk factor for the incidence of depression [Hazard Ratio per unit increase (HR); 95% Confidence Interval (CI): 1.13; 1.09-1.17] and anxiety [HR; 95% CI: 1.14; 1.09-1.18]. Associations attenuated but remained statistically significant after adjusting for socio-demographic characteristics, chronic somatic disorders, and baseline levels of (subclinical) depressive or anxiety symptoms [adjusted HR for depression; 95% CI: 1.06; 1.00-1.12, adjusted HR for anxiety; 95% CI: 1.13; 1.07-1.20]. Conclusion: Persons who somatise have an increased risk of becoming depressed or anxious in subsequent years, over and above baseline levels of depressive or anxiety symptoms. They may represent a target group for prevention of depressive and anxiety disorders.
U2 - 10.1016/j.jpsychores.2015.07.007
DO - 10.1016/j.jpsychores.2015.07.007
M3 - Article
SN - 0022-3999
VL - 79
SP - 614
EP - 619
JO - Journal of Psychosomatic Research
JF - Journal of Psychosomatic Research
IS - 6
ER -